Literature DB >> 15965758

Pancaspase and cardiac function after infarction.

Friedrich C Luft1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15965758     DOI： 10.1007/s00109-005-0674-0

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN： 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  6 in total

Review 1.  Baculoviruses and apoptosis: the good, the bad, and the ugly.

Authors:  R J Clem
Journal:  Cell Death Differ       Date:  2001-02       Impact factor: 15.828

Review 2.  The mitochondrial death pathway and cardiac myocyte apoptosis.

Authors:  Michael T Crow; Kartik Mani; Young-Jae Nam; Richard N Kitsis
Journal:  Circ Res       Date:  2004-11-12       Impact factor: 17.367

3.  Gene transfer of the pancaspase inhibitor P35 reduces myocardial infarct size and improves cardiac function.

Authors:  Lorenz Bott-Flügel; Hans-Jörg Weig; Martina Knödler; Christian Städele; Alessandra Moretti; Karl-Ludwig Laugwitz; Melchior Seyfarth
Journal:  J Mol Med (Berl)       Date:  2005-06-21       Impact factor: 4.599

4.  Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor.

Authors:  H Yaoita; K Ogawa; K Maehara; Y Maruyama
Journal:  Circulation       Date:  1998-01-27       Impact factor: 29.690

Review 5.  Role of apoptosis in remodeling after myocardial infarction.

Authors:  Genzou Takemura; Hisayoshi Fujiwara
Journal:  Pharmacol Ther       Date:  2004-10       Impact factor: 12.310

6.  Inhibition of granulation tissue cell apoptosis during the subacute stage of myocardial infarction improves cardiac remodeling and dysfunction at the chronic stage.

Authors:  Kenji Hayakawa; Genzou Takemura; Motoo Kanoh; Yiwen Li; Masahiko Koda; Yukinori Kawase; Rumi Maruyama; Hideshi Okada; Shinya Minatoguchi; Takako Fujiwara; Hisayoshi Fujiwara
Journal:  Circulation       Date:  2003-06-23       Impact factor: 29.690
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.